Table 2.
Donor | ≤12 mo | 2–3 y | 4 y | |||
---|---|---|---|---|---|---|
NoV GI.3/GII.4 | RV | NoV GI.3/GII.4 | RV | NoV GI.3/GII.4 | RV | |
1a | −/− | — | −/− | N/A | +/− | — |
2 | −/− | — | −/− | + | N/A | N/A |
3b | −/− | — | −/− | — | +/+ | + |
4 | −/− | — | −/+ | + | +/− | + |
5a | +/+ | + | +/+ | + | +/+ | + |
6 | −/+ | + | N/A | N/A | N/A | N/A |
7 | −/+ | + | +/+ | + | +/− | + |
8 | −/+ | + | +/+ | + | +/+ | + |
9 | −/+ | + | N/A/+ | + | N/A/— | N/A |
10 | −/− | + | −/+ | + | +/+ | + |
aReceived RV vaccine (3 doses) before 6 months of age.
bReceived RV vaccine (1 dose) before 3 months of age.
−, a negative readout (below the cut-off level) in ELISPOT IFN-γ assay. +, a positive readout (above the cut-off level) in ELISPOT IFN-γ assay. N/A, not available.